Literature DB >> 28116782

Primary cutaneous diffuse large B-cell lymphoma presenting as chronic non-healing ulcer.

Victoria L Billero1, Charlotte E LaSenna1, Marco Romanelli2, Alessio Giubellino1, Robert A Brenes3, Paolo Romanelli1.   

Abstract

Primary cutaneous diffuse large B-cell lymphoma is an uncommon and aggressive lymphoproliferative disorder with a rapid growth rate and dismal prognosis. We present the case of a 91-year-old female with an unusual manifestation of primary cutaneous diffuse large B-cell lymphoma, mimicking other more prevalent diseases like chronic non-healing venous ulceration. Dermatopathologic evaluation rendered the correct diagnosis. A discussion of this rare presentation is important for clinician consideration to prevent misdiagnosis and prolongation of proper management in patients with chronic non-healing leg ulcers.
© 2017 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic ulcer; Dermatopathology; Leg ulcer; Non-healing ulcer; Primary cutaneous diffuse large B-cell lymphoma leg-type

Mesh:

Year:  2017        PMID: 28116782      PMCID: PMC7949661          DOI: 10.1111/iwj.12716

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  14 in total

1.  Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases.

Authors:  Y M Kirova; Y Piedbois; J P Le Bourgeois
Journal:  Radiother Oncol       Date:  1999-07       Impact factor: 6.280

Review 2.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

Authors:  R Willemze; H Kerl; W Sterry; E Berti; L Cerroni; S Chimenti; J L Diaz-Peréz; M L Geerts; M Goos; R Knobler; E Ralfkiaer; M Santucci; N Smith; J Wechsler; W A van Vloten; C J Meijer
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

3.  Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.

Authors:  Cristina Muniesa; Ramon M Pujol; M Teresa Estrach; Fernando Gallardo; M Pilar García-Muret; Josefina Climent; Antonio Salar; Octavio Servitje
Journal:  J Am Acad Dermatol       Date:  2011-08-03       Impact factor: 11.527

Review 4.  Primary cutaneous B-cell lymphoma: a clinically homogeneous entity?

Authors:  N Pimpinelli; M Santucci; M Mori; C Vallecchi; B Giannotti
Journal:  J Am Acad Dermatol       Date:  1997-12       Impact factor: 11.527

5.  Cutaneous large B-cell lymphoma of the leg masquerading as a chronic venous ulcer.

Authors:  A Garbea; E Dippel; R Hildenbrand; U Bleyl; D Schadendorf; S Goerdt
Journal:  Br J Dermatol       Date:  2002-01       Impact factor: 9.302

6.  Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases.

Authors:  M Santucci; N Pimpinelli; L Arganini
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

7.  Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma.

Authors:  L Heinzerling; R Dummer; W Kempf; M H Schmid; G Burg
Journal:  Arch Dermatol       Date:  2000-03

8.  Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.

Authors:  M H Vermeer; F A Geelen; C W van Haselen; P C van Voorst Vader; M L Geerts; W A van Vloten; R Willemze
Journal:  Arch Dermatol       Date:  1996-11

Review 9.  The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

Authors:  Elaine S Jaffe
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 10.  European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

Authors:  Nancy J Senff; Evert M Noordijk; Youn H Kim; Martine Bagot; Emilio Berti; Lorenzo Cerroni; Reinhard Dummer; Madeleine Duvic; Richard T Hoppe; Nicola Pimpinelli; Steven T Rosen; Maarten H Vermeer; Sean Whittaker; Rein Willemze
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.